📰 Lass Action News
Page 17 - Lass Action News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lass Action. Real-time updates on events, politics, business and more.
April 26, 2024
LOS ANGELES, April 26, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 28, 2024 deadline to file a...
April 26, 2024
LOS ANGELES, April 26, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf...
April 26, 2024
NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United...
April 26, 2024
NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities...
April 26, 2024
LOS ANGELES, April 26, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf...
April 26, 2024
NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies...
April 26, 2024
NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities...
April 26, 2024
BENSALEM, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf...
April 26, 2024
Robbins LLP is Investigating the Allegations that Checkpoint Therapeutics, Inc. Overstated the Prospects of its Lead Product Candidate, Cosibelimab ...
April 26, 2024
Robbins LLP is Investigating the Allegations that Bluebird Bio, Inc. (BLUE) Overstated the Clinical and/or Commercial Prospects of its Drug ...